LV15518A - Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze - Google Patents

Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze

Info

Publication number
LV15518A
LV15518A LVP-19-08A LV190008A LV15518A LV 15518 A LV15518 A LV 15518A LV 190008 A LV190008 A LV 190008A LV 15518 A LV15518 A LV 15518A
Authority
LV
Latvia
Prior art keywords
aziridine
carboxamide
derivatives
inhibitors
cancer
Prior art date
Application number
LVP-19-08A
Other languages
English (en)
Inventor
Raivis ŽALUBOVSKIS
Jekaterīna IVANOVA
Ilona Domračeva
Iveta KAŅEPE-LAPSA
Ivars KŪMS
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-19-08A priority Critical patent/LV15518A/lv
Priority to PCT/IB2019/060350 priority patent/WO2020170022A1/en
Publication of LV15518A publication Critical patent/LV15518A/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/16—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms
    • C07D203/18—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with acylated ring nitrogen atoms by carboxylic acids, or by sulfur or nitrogen analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Izgudrojums ir saistīts ar jaunām potenciāli terapeitiskām vielām, kas satur 1-acil-aziridīn-2-karboksamīda atvasinājumus un to analogus, kam piemīt pretvēža un/vai antiproliferatīvas, vai antimetastātiskas īpašības. Šie savienojumi ir tioredoksīnreduktāzes inhibitori.
LVP-19-08A 2019-02-18 2019-02-18 Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze LV15518A (lv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-19-08A LV15518A (lv) 2019-02-18 2019-02-18 Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze
PCT/IB2019/060350 WO2020170022A1 (en) 2019-02-18 2019-12-02 Derivatives of aziridine-2-carboxamide as inhibitors of thioredoxin reductase, their synthesis, anti-cancer and anti-metastatic effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-19-08A LV15518A (lv) 2019-02-18 2019-02-18 Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze

Publications (1)

Publication Number Publication Date
LV15518A true LV15518A (lv) 2020-08-20

Family

ID=65598692

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-19-08A LV15518A (lv) 2019-02-18 2019-02-18 Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze

Country Status (2)

Country Link
LV (1) LV15518A (lv)
WO (1) WO2020170022A1 (lv)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2731264A1 (de) * 1977-07-11 1979-02-01 Boehringer Mannheim Gmbh Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen
JPH11322593A (ja) * 1998-03-19 1999-11-24 Sagami Chem Res Center アセトアミド誘導体を有効成分とする抗癌剤及びチュ―ブリン阻害剤、並びに新規アセトアミド誘導体

Also Published As

Publication number Publication date
WO2020170022A1 (en) 2020-08-27

Similar Documents

Publication Publication Date Title
MX2023005804A (es) Piridazinonas como inhibidoras de poli(adenosin difosfato-ribosa) polimerasa 7 (parp7).
MX2022005216A (es) Piridazinonas como inhibidores de poli(adp-ribosa) polimerasa 7 (parp7).
PH12016502504A1 (en) Mnk inhibitors and methods related thereto
NZ742742A (en) Compositions and methods for inhibiting arginase activity
MX2016010296A (es) Compuestos farmaceutios.
PH12017502051A1 (en) TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF
CY1119900T1 (el) Διμερης βουπρενορφινη και η χρηση της στη θεραπευτικη αγωγη γαστρεντερικων διαταραχων
MX2020006365A (es) Quinazolinonas como inhibidores de poli(adenosin difosfato-ribosa)polimerasa 14 (parp14).
WO2017223280A3 (en) COMPOSITIONS AND METHODS FOR RELEASING THERAPEUTIC AGENTS
MX353299B (es) Metodos y composiciones relacionadas con p62 para el tratamiento y profilaxis del cancer.
PH12020551390A1 (en) AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
MX2017012102A (es) Agentes citotoxicos bifuncionales que contienen el farmacoforo de cti.
MY181641A (en) Amino pyran ring derivative and composition and use thereof
MX2017010297A (es) Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
MX2019006863A (es) Inhibidores de heparanasa y uso de los mismos.
IN2015CH01182A (lv)
MX2021008225A (es) Composiciones y metodos para tratamiento de crecimiento celular anormal.
MX2019008375A (es) Tiobenzoimidazol como fungicidas.
IL279168B (en) A process for the preparation of eribulin
LV15518A (lv) Aziridīn-2-karboksamīda atvasinājumi kā tioredoksīnreduktāzes inhibitori ar pretvēža un pretmetastatisku iedarbību un to sintēze
PH12017501897A1 (en) 2-thiopyrimidinones
JOP20200104A1 (ar) مركبات مثبطة لـ btk
JOP20210327A1 (ar) مركبات وسيطة سبيرو ثنائية الحلقة جديدة
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs